Table 2.
Elements of Care Performed as Part of mpox Evaluation by Clinical Site
| All Patients | Patients With Positive mpox Test | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis Site | Diagnosis Site | |||||||||
| Total | ID | PCP | ED | P value | Total | ID | PCP | ED | P value | |
| N | 276 | 51 (18.5%) | 52 (18.8%) | 173 (62.7%) | 73 | 26 (35.6%) | 8 (11.0%) | 39 (53.4%) | ||
| Sexual history performed | <.001 | .091 | ||||||||
| Yes | 211 (76.4%) | 50 (98.0%) | 42 (80.8%) | 119 (68.8%) | 66 (90.4%) | 26 (100.0%) | 7 (87.5%) | 33 (84.6%) | ||
| No | 65 (23.6%) | 1 (2.0%) | 10 (19.2%) | 54 (31.2%) | 7 (9.6%) | 0 (0.0%) | 1 (12.5%) | 6 (15.4%) | ||
| Anogenital examination performeda | <.001 | .136 | ||||||||
| Yes | 140 (50.7%) | 42 (82.4%) | 21 (40.4%) | 77 (44.5%) | 55 (75.3%) | 22 (84.6%) | 4 (50.0%) | 29 (74.4%) | ||
| No | 136 (49.3%) | 9 (17.6%) | 31 (59.6%) | 96 (55.5%) | 18 (24.7%) | 4 (15.4%) | 4 (50.0%) | 10 (25.6%) | ||
| Any STI test performedb | <.001 | .716 | ||||||||
| Yes | 154 (55.8%) | 41 (80.4%) | 20 (38.5%) | 93 (53.8%) | 54 (74.0%) | 20 (76.9%) | 5 (62.5%) | 29 (74.4%) | ||
| No | 122 (44.2%) | 10 (19.6%) | 32 (61.5%) | 80 (46.2%) | 19 (26.0%) | 6 (23.1%) | 3 (37.5%) | 10 (25.6%) | ||
| Any gonorrhea test | <.001 | .223 | ||||||||
| Yes | 105 (38.0%) | 37 (72.5%) | 12 (23.1%) | 56 (32.4%) | 47 (64.4%) | 20 (76.9%) | 4 (50.0%) | 23 (59.0%) | ||
| No | 171 (62.0%) | 14 (27.5%) | 40 (76.9%) | 117 (67.6%) | 26 (35.6%) | 6 (23.1%) | 4 (50.0%) | 16 (41.0%) | ||
| Any chlamydia test | <.001 | .268 | ||||||||
| Yes | 105 (38.0%) | 36 (70.6%) | 12 (23.1%) | 57 (32.9%) | 48 (65.8%) | 20 (76.9%) | 4 (50.0%) | 24 (61.5%) | ||
| No | 171 (62.0%) | 15 (29.4%) | 40 (76.9%) | 116 (67.1%) | 25 (34.2%) | 6 (23.1%) | 4 (50.0%) | 15 (38.5%) | ||
| Extragenital gonorrhea test | <.001 | <.001 | ||||||||
| Yes | 52 (18.8%) | 34 (66.7%) | 6 (11.5%) | 12 (6.9%) | 28 (38.4%) | 18 (69.2%) | 3 (37.5%) | 7 (17.9%) | ||
| No | 224 (81.2%) | 17 (33.3%) | 46 (88.5%) | 161 (93.1%) | 45 (61.6%) | 8 (30.8%) | 5 (62.5%) | 32 (82.1%) | ||
| Extragenital chlamydia test | <.001 | <.001 | ||||||||
| Yes | 52 (18.8%) | 33 (64.7%) | 6 (11.5%) | 13 (7.5%) | 29 (39.7%) | 18 (69.2%) | 3 (37.5%) | 8 (20.5%) | ||
| No | 224 (81.2%) | 18 (35.3%) | 46 (88.5%) | 160 (92.5%) | 44 (60.3%) | 8 (30.8%) | 5 (62.5%) | 31 (79.5%) | ||
| Syphilis testing performed | .011 | .107 | ||||||||
| Yes | 110 (39.9%) | 26 (51.0%) | 12 (23.1%) | 72 (41.6%) | 40 (54.8%) | 13 (50.0%) | 2 (25.0%) | 25 (64.1%) | ||
| No | 166 (60.1%) | 25 (49.0%) | 40 (76.9%) | 101 (58.4%) | 33 (45.2%) | 13 (50.0%) | 6 (75.0%) | 14 (35.9%) | ||
| HIV test performedc | .208 | .966 | ||||||||
| Yes | 77 (36.7%) | 4 (66.7%) | 15 (30.6%) | 58 (37.4%) | 17 (47.2%) | 1 (50.0%) | 3 (42.9%) | 13 (48.1%) | ||
| No | 133 (63.3%) | 2 (33.3%) | 34 (69.4%) | 97 (62.6%) | 19 (52.8%) | 1 (50.0%) | 4 (57.1%) | 14 (51.9%) | ||
| Combined outcomed | <.001 | .038 | ||||||||
| Yes | 95 (34.4%) | 33 (64.7%) | 12 (23.1%) | 50 (28.9%) | 40 (54.8%) | 16 (61.5%) | 1 (12.5%) | 23 (59.0%) | ||
| No | 181 (65.6%) | 18 (35.3%) | 40 (76.9%) | 123 (71.1%) | 33 (45.2%) | 10 (38.5%) | 7 (87.5%) | 16 (41.0%) | ||
Abbreviations: ED, emergency department; ID, infectious diseases; PCP, primary care provider; STI, sexually transmitted infection.
aExamination performed at index visit or immediately before index visit.
bIncludes any person with at least 1 gonorrhea, chlamydia, syphilis, or HIV test.
cAmong persons not known to have HIV infection.
dEvalution included sexual history, anogenital examination, ≥ 1 additional STI test.